TORONTO, April 28, 2021 /CNW/ – Syqe Medical®, a leading global pharma-tech company, announces today that Health Canada has approved the Syqe® Inhaler, the first pharmaceutical grade medical cannabis delivery device system that provides predictable and consistent dosing through inhalation.
Read more here.
![[Hailo in Forbes] Israeli Startups Have Raised $3.1 Billion Since October 7](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-link.svg)
![[uBeam in PR Newswire] uBeam to Unveil Ultrasonic Wireless Power System at CES 2019](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
